ClinicalTrials.gov
public full text
Public Domain
Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance
Clomiphene citrate resistance (CCR) occur in 15-40% in women with PCOS. Several studies have shown that letrozole is superior to CC regarding side effects, ovulation, and pregnancy rates. Letrozole or gonadotropins use for ovulation induction in CCR is not well established which is superior and most safe.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- BMI Effect on the Response to Ovulation Induction in Letrozole vs Clomid#1010047
- Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer#812580
- Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS#806297
- Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone#885182
- Inositol in Letrozol Resistant PCOS Women#290957
Record · ID 993718
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive